BridgeBio Pharma, Inc. revenue breakdown overview

BridgeBio Pharma, Inc. revenue for the last year amounted to 9.30 M USD, the most of which — 9.30 M USD — came from its highest performing source at the moment, Transformative Medicines, the year earlier bringing 77.65 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought BridgeBio Pharma, Inc. 9.30 M USD, and the year before that — 77.65 M USD.